Recent Advances in Novel Antiviral Therapies against Human Adenovirus
Open Access
- 22 August 2020
- journal article
- review article
- Published by MDPI AG in Microorganisms
- Vol. 8 (9) , 1284
Abstract
Human adenovirus (HAdV) is a very common pathogen that typically causes minor disease in most patients. However, the virus can cause significant morbidity and mortality in certain populations, including young children, the elderly, and those with compromised immune systems. Currently, there are no approved therapeutics to treat HAdV infections, and the standard treatment relies on drugs approved to combat other viral infections. Such treatments often show inconsistent efficacy, and therefore, more effective antiviral therapies are necessary. In this review, we discuss recent developments in the search for new chemical and biological anti-HAdV therapeutics, including drugs that are currently undergoing preclinical/clinical testing, and small molecule screens for the identification of novel compounds that abrogate HAdV replication and disease.Keywords
Funding Information
- Canadian Institutes of Health Research (MOP-136898, MOP-142316)
- Natural Sciences and Engineering Research Council of Canada (RGPIN-2014-04810, RGPIN-2019-04786)
- Government of Ontario (Ontario Graduate Scholarship, Queen Elizabeth II Graduate Scholarship in Science and Technology)
This publication has 173 references indexed in Scilit:
- Structure of human adenovirusCurrent Opinion in Virology, 2012
- Chromatin structure of adenovirus DNA throughout infectionNucleic Acids Research, 2011
- Cellular and viral chromatin proteins are positive factors in the regulation of adenovirus gene expressionNucleic Acids Research, 2010
- Inhibition of adenovirus infections by siRNA-mediated silencing of early and late adenoviral gene functionsAntiviral Research, 2010
- Crystal Structure of Human Adenovirus at 3.5 Å ResolutionScience, 2010
- Inhibition of the histone demethylase LSD1 blocks α-herpesvirus lytic replication and reactivation from latencyNature Medicine, 2009
- Transcriptional control by adenovirus E1A conserved region 3 via p300/CBPNucleic Acids Research, 2009
- Inhibitors of the sodium potassium ATPase that impair herpes simplex virus replication identified via a chemical screening approachVirology, 2007
- The impact of adenovirus infection on the immunocompromised hostReviews in Medical Virology, 2003
- Promoter targeting by adenovirus E1a through interaction with different cellular DNA-binding domainsNature, 1994